Efficacy and safety of DPP-1 inhibitors in bronchiectasis: a GRADE-assessed meta-analysis of randomized controlled trials Article (Faculty180)

cited authors

  • Emara, Ahmed; Awashra, Ameer; Ellebedy, Mohamed; Abbas, Omar F; Diaa, Ahmed; Elgendy, Mohamed S; Emara, Mohamed; Shubietah, Abdalhakim; Abdeen, Abdul Muhsen Z; Safi, Fadi

description

  • Bronchiectasis is a chronic inflammatory airway disease characterized by frequent exacerbations and neutrophilic inflammation. Dipeptidyl peptidase-1 (DPP-1) inhibitors block neutrophil serine protease activation and represent a promising therapeutic approach. This meta-analysis aimed to evaluate the efficacy and safety of DPP-1 inhibitors in adults with bronchiectasis.

authors

publication date

  • 2025

published in

start page

  • 332

volume

  • 26